Latest Breaking News On - The gale - Page 1 : comparemela.com

SYFOVRE reduced nonsubfoveal GA lesion growth by up to 45% between Months 24-30 compared to projected sham in the GALE long-term extension study Safety profile of SYFOVRE in GALE was consistent with previously reported clinical dataData presented during an oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting A Media Snippet accompanying this announcement is available by clicking on the image or link below: WALTHAM, Mass., July 30, 2023 (GLOBE NEWSWIRE)

United kingdomUnited statesMeredith kayaCaroline baumalLissa pavlukAmerican society of retina specialistsLancet glob healthExchange commission onExchange commissionApellis pharmaceuticals incResearch groupAmerican societyRetina specialistsAnnual scientificTerm extensionGeographic atrophy